Sign In
Buy VIR
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
3 Biotech Stocks to Buy Now for Extraordinary Gains
09:16pm, Tuesday, 20'th Sep 2022
Biotech stocks have performed relatively well compared to the broader market of late. The SPDR S&P Biotech ETF (NYSEARCA: XBI ) is up 21% over the past three months compared with a 6% gain for the S&P
This Hepatitis Stock Has 'Multiple Paths To Value Creation,' Expects To Double, Bullish Analyst Predicts
06:11pm, Wednesday, 14'th Sep 2022 Benzinga
SVB Leerink initiated coverage on Vir Biotechnology Inc (NASDAQ: VIR) with an Outperform rating and a price target of $40, with an investment thesis based on:
With multiple clinic programs, Vir is
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
02:07pm, Wednesday, 14'th Sep 2022 Benzinga
Upgrades
For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low
Is the Options Market Predicting a Spike in Vir Biotechnology (VIR) Stock?
12:56pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Investors need to pay close attention to Vir Biotechnology (VIR) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Vir Biotechnology (VIR) Stock?
10:28am, Wednesday, 14'th Sep 2022
Investors need to pay close attention to Vir Biotechnology (VIR) stock based on the movements in the options market lately.
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
02:40pm, Friday, 09'th Sep 2022 Benzinga
Upgrades
For 3M Co (NYSE:MMM), UBS upgraded the previous rating of Sell to Neutral. For the second quarter, 3M had an EPS of $2.48, compared to year-ago quarter EPS of $2.59. The current stock perform
Vir Biotechnology to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
08:05pm, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the Morgan Stanley 20th Annual Global
Vir Biotechnology to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
04:05pm, Tuesday, 06'th Sep 2022
SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the Morgan Stanley 20th Annual Global He
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
10:05pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of -241.18% and 129.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stoc
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
08:02pm, Tuesday, 09'th Aug 2022 GlobeNewswire Inc.
– More than $2.6 billion in cash, cash equivalents, investments and profit-share payments to be received from GSK expected to fund the company’s ongoing operations and liabilities for up to five
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
07:33pm, Tuesday, 09'th Aug 2022
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of -241.18% and 129.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stoc
Emergent Biosolutions (EBS) Reports Q2 Loss, Misses Revenue Estimates
10:15pm, Monday, 01'st Aug 2022 Zacks Investment Research
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -236.51% and 16.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Avidity Biosciences, Inc. (RNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
Avidity Biosciences, Inc. (RNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Fast-Growing Stocks to Buy Now
01:00pm, Sunday, 31'st Jul 2022 The Motley Fool
ShockWave, Vir, and BioCryst are all seeing skyrocketing sales this quarter.
3 Fast-Growing Stocks to Buy Now
09:00am, Sunday, 31'st Jul 2022
ShockWave, Vir, and BioCryst are all seeing skyrocketing sales this quarter.
